503b tirzepatide pharmacy FDA ban on compounded tirzepatide: Switch to name brand medications Is 503B the New 340B?:

van den Berg et al, 1996

Promising therapeutics include semaglutide (Ozempic and Wegovy ), an agonist for glucagon-like peptide-1 (GLP-1) receptor, and tirzepatide (Mounjaro ), a dual agonist for GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors

Here is the part most older articles get wrong now

Vigilance on new-onset atherosclerosis following SARS-CoV-2 infection

To compare the safety of these supplements with one another, we considered moderate doses to be among the safest

The single-cell transcriptomic results indicated that in response to ischemic cardiac injury, pericytes expressed an overabundance of genes related to vascular permeability, proliferation, extracellular matrix (ECM) production, and fibrosis, peaking at post-injury day 7